Litigation Details for Boehringer Ingelheim Pharmaceuticals Inc. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2020-02-04
Court	District Court, N.D. West Virginia	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Irene Patricia Murphy Keeley
Jury Demand		Referred To
Patents	10,022,379; 10,034,877; 8,853,156; 9,415,016; 9,486,526
Link to Docket	External link to docket

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2021-07-08	160	Order (PUBLIC) AND Memorandum & Opinion	the ’526 patent, U.S. Patent No. 9,415,016 (“the ’016 patent”), and U.S. Patent No. 10,022,379 (“the ’…U.S. Patent No. 8,853,156 (Dkt. No. 72-10 at 2). U.S. Patent No. 10,034,877 (“the ’877 patent”) is a …the ’526 patent, (Dkt. Nos. 72, 73), the 3 The ’016 patent and the ’379 patent concern …the ’877 patent is instructive because that patent is a continuation of the ’526 patent and the two…CONSTRUCTION This patent infringement case involves three United States Patents issued to Boehringer	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document